SCHEMBL4958548

SCHEMBL4958548

NC(=O)OCC(c1nnn[nH]1)c1ccc(F)cc1F

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
PKM P14618 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33
ALPL P05186 2/20 0.33
TDP1 Q9NUW8 1/20 0.31
DPP9 Q86TI2 1/20 0.30
KCNN4 O15554 1/20 0.30
OXTR P30559 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4962125 0.85 CYP1A2 (0.41) CES2CES1CYP1A2CYP2D6PKM
SCHEMBL4960423 0.80 CYP1A2 (0.38) CES2CES1CYP1A2CYP2D6PKM
SCHEMBL4959934 0.79 CYP1A2 (0.38) CYP1A2CYP2D6PKMSMN1; SMN2NPSR1
SCHEMBL4959933 0.78 CYP1A2 (0.41) CYP1A2CYP2D6PKMSMN1; SMN2NPSR1
SCHEMBL4958574 0.74 SMN1; SMN2 (0.38) CYP1A2CYP2D6PKMSMN1; SMN2NPSR1
SCHEMBL4312868 0.73 CES2 (0.34) CES2CES1IDO1TDO2ALPL
SCHEMBL4960360 0.72 CYP1A2 (0.33) CYP1A2CYP2D6PKMSMN1; SMN2NPSR1
SCHEMBL4960105 0.70 SMN1; SMN2 (0.43) CYP1A2CYP2D6PKMSMN1; SMN2NPSR1
SCHEMBL4958729 0.70 SMN1; SMN2 (0.38) CYP1A2CYP2D6PKMSMN1; SMN2NPSR1
SCHEMBL4962975 0.67 ALOX5 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879873-A1 NEUROTHERAPEUTIC AZOLE COMPOUNDS SK Holdings Co., Ltd. (KR) 2008-01-23 EP disclosed
WO-2006112685-A1 NEUROTHERAPEUTIC AZOLE COMPOUNDS SK HOLDINGS CO., LTD. (KR) 2006-10-26 WO disclosed